TH-302

Is Threshold on the Threshold of Something Big?

Is Threshold on the Threshold of Something Big?

Motley Fool

What's Left For Threshold? Not Much

What's Left For Threshold? Not Much

Seeking Alpha

Threshold announces preliminary data from TH-302 study

Threshold announces preliminary data from TH-302 study

Yahoo/Fly on the Wall

Threshold Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma

Threshold Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma

Yahoo/MarketWire

Threshold's Pancreatic Cancer Drug Boosts Survival -- With an Asterisk

Threshold's Pancreatic Cancer Drug Boosts Survival -- With an Asterisk

TheStreet.com

2 Drug Combination Stocks Targeting Leukemia

2 Drug Combination Stocks Targeting Leukemia

Seeking Alpha

Threshold Pharmaceutical's TH-302 Could Be A Blockbuster By Targeting Hypoxia In Cancer

Threshold Pharmaceutical's TH-302 Could Be A Blockbuster By Targeting Hypoxia In Cancer

Seeking Alpha

Threshold Pharmaceuticals: TH-302 Phase IIb Clinical Results In First-Line Pancreatic Cancer

Threshold Pharmaceuticals: TH-302 Phase IIb Clinical Results In First-Line Pancreatic Cancer

Seeking Alpha

Threshold’s cancer drug gets Orphan Drug designation

Threshold’s cancer drug gets Orphan Drug designation

Proactive Investors

Threshold Scores Big With Pancreatic Cancer Data

Threshold Scores Big With Pancreatic Cancer Data

Seeking Alpha